Is your Oxycodone testing effective?
In this webinar, Dr. Anthony Costantino provides peer to peer education by sharing the importance of targeted testing and detection of Oxycodone.
In his presentation, Dr. Costantino will discuss:
- Why is targeted testing and detection important?
- What are the benefits of testing?
- How does it impact your patients?
Speaker:
Dr. Costantino is a board-certified toxicologist and has over 30 years of experience in clinical, forensic, and analytical toxicology.
Dr. Costantino earned a Ph.D. in Forensic Toxicology at the University of Maryland, School of Medicine and is board certified by the American Board of Forensic Toxicology. He received his B.S. in Pharmacy and an M.S. in Pharmacology/Toxicology from Duquesne University in Pittsburgh, Pennsylvania.
Dr. Costantino is considered a thought leader in the field of toxicology and has authored over 30 scientific publications. He has served on numerous corporate and advisory boards and has served the SAMHSA Center for Drug Abuse Prevention’s Drug Testing Advisory Board (DTAB). The SAMHSA program often sets the precedent for other testing in the field of toxicology. He is a former President of the Society of Forensic Toxicologists, Inc. (SOFT), an organization composed of practicing forensic toxicologists that are interested in the discipline of promoting and developing forensic toxicology. Dr. Costantino is also a Fellow of the American Board of Forensic Toxicology (ABFT).
He was most recently and from 2008-2020 the President, CEO and Laboratory Director of DRUGSCAN, Inc. in Horsham, Pennsylvania
Prior to DRUGSCAN, Dr. Costantino was Vice President of Operations at NMS Labs, a national reference toxicology laboratory. From 1991 to 2002, he was Senior Vice President and Director of Toxicology with American Medical Laboratories (AML), now Quest Diagnostics Nichols Institute, where he was responsible for the clinical and forensic toxicology laboratory business units including a SAMHSA certified laboratory, as well as an industrial hygiene laboratory. Dr. Costantino is currently adjunct faculty at Thomas Jefferson University where he teaches a graduate level class in Interpretative Toxicology and is the President of Costantino Consulting Services, Inc.
